This review discusses the causes, pathogenesis, and clinical management of membranoproliferative glomerulonephritis, which accounts for 7 to 10% of biopsy-confirmed glomerulonephritis cases. Current classification reflects advances in the understanding of this condition.
No takes yet. Share an insight, caveat, or question.
Sethi et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: